Literature DB >> 31282781

Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation.

Kah Poh Loh1, Andrea Baran1, Christina Y Lee2, Alfadel Alshaibani2, Sarah C Rutherford2, John Hu3, Carla Casulo1, Paul M Barr1, Jonathan W Friedberg1, Patrick M Reagan1.   

Abstract

Entities:  

Year:  2019        PMID： 31282781     DOI： 10.1080/10428194.2019.1639172

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

Review 1.  DA-R-EPOCH vs R-CHOP in DLBCL: How do we choose?

Authors:  Ajay Major; Sonali M Smith
Journal:  Clin Adv Hematol Oncol       Date:  2021-11

2.  Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?

Authors:  Arushi Khurana; Raphael Mwangi; Grzegorz S Nowakowski; Thomas M Habermann; Stephen M Ansell; Betsy R LaPlant; Brian K Link; James R Cerhan; Matthew J Maurer; Thomas E Witzig
Journal:  J Clin Oncol       Date:  2021-02-02       Impact factor: 44.544
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.